BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3297874)

  • 21. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.
    Böhle A; Bock PR
    Urology; 2004 Apr; 63(4):682-6; discussion 686-7. PubMed ID: 15072879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
    Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
    Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
    Yi SZ; Zhang DC; Wang YG; Sun KL
    Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
    Berghmans T; Tragas G; Sculier JP
    Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
    Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
    Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [BCG immunotherapy in malignant lymphogranuloma].
    Dientsbier Z; Foltýnová V; Hermanská Z; Chytrý P; Maríková E
    Sb Lek; 1991 May; 93(3-4):84-94. PubMed ID: 1853142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
    Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
    Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
    Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)].
    Titscher R; Micksche M
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():371-2. PubMed ID: 461311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

  • 33. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
    Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
    Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
    Fair WR; Betancourt JE
    Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].
    Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I
    Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].
    Yildirim C; Küçük AI; Ongüt G; Oğünç D; Colak D; Mutlu G
    Mikrobiyol Bul; 2009 Jan; 43(1):27-35. PubMed ID: 19334377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer.
    Bottomley A; Debruyne C; Felip E; Millward M; Thiberville L; D'Addario G; Rome L; Zatloukal P; Coens C; Giaccone G
    Eur J Cancer; 2008 Oct; 44(15):2178-84. PubMed ID: 18676140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.
    Jänne PA; Freidlin B; Saxman S; Johnson DH; Livingston RB; Shepherd FA; Johnson BE
    Cancer; 2002 Oct; 95(7):1528-38. PubMed ID: 12237922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [BCG vaccine immunotherapy after radical operations for lung cancer].
    Repin IuM
    Vestn Khir Im I I Grek; 1992; 149(7-8):11-6. PubMed ID: 1341347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.